BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Adult Hodgkin lymphoma AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Diagnosis
284 results:

  • 1. Epidemiology of pediatric hematological malignancies in Kazakhstan: Data from Unified National Electronic Healthcare System 2014-2021.
    Mussina K; Kuanova B; Syssoyev D; Gaipov A; Poddighe D; Shaikhyzada K; Aimyshev T; Galiyeva D
    Eur J Pediatr; 2024 Apr; 183(4):1683-1691. PubMed ID: 38214809
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma-presentation in novel settings and comprehensive review of literature.
    Ghezavati A; Liang CA; Mais D; Nazarullah A
    J Hematop; 2023 Sep; 16(3):167-175. PubMed ID: 38175402
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Optimal dosage of rituximab for children with Burkitt lymphoma.
    Huang S; Jin L; Yang J; Zhang M; Zhang Y; Peng Y; Duan Y; Zheng H
    Ann Hematol; 2024 Mar; 103(3):893-903. PubMed ID: 38091052
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Characteristics and impact factors of SARS-CoV-2 infection in adult patients with relapsed/refractory B-cell non-hodgkin lymphoma receiving chimeric antigen receptor T-cell therapy].
    Ge T; Liu H; Wang ZH; Cao Y; Zhang YC; Huang L; Qian WB; Zhou XX
    Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):825-831. PubMed ID: 38049334
    [No Abstract]    [Full Text] [Related]  

  • 5. Spontaneous tumor lysis syndrome in a patient with chronic myeloid leukemia treated successfully with allopurinol.
    Gartenberg A; Winkel M; Leonard N
    Am J Emerg Med; 2024 Apr; 78():242.e1-242.e3. PubMed ID: 38007380
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Health Care Resource Utilization and Total Costs of Care for adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis.
    Ito D; Feng C; Fu C; Kim C; Wu J; Dalton D; Epstein J; Snider JT; DuVall AS
    Clin Ther; 2024 Jan; 46(1):3-11. PubMed ID: 37981560
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of Social Disparities on 5-Year Survival Rates in Pediatric Hematologic Malignancies.
    Chalfant V; Riveros C; Bechtel A; Bradfield SM; Stec AA
    J Pediatr Hematol Oncol; 2024 Jan; 46(1):33-38. PubMed ID: 37910818
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Testicular dysfunction at diagnosis in children and teenagers with haematopoietic malignancies improves after initial chemotherapy.
    Lopez Dacal J; Prada S; Correa Brito L; Ropelato MG; Ballerini MG; Rodriguez ME; Gutiérrez ME; Soria M; Morán L; Ferraro C; Bedecarrás P; Drelichman G; Aversa L; Bergadá I; Rey RA; Grinspon RP
    Front Endocrinol (Lausanne); 2023; 14():1135467. PubMed ID: 37260445
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Late-onset Cognitive Impairment and Modifiable Risk Factors in adult Childhood Cancer Survivors.
    Phillips NS; Stratton KL; Williams AM; Ahles T; Ness KK; Cohen HJ; Edelstein K; Yasui Y; Oeffinger K; Chow EJ; Howell RM; Robison LL; Armstrong GT; Leisenring WM; Krull KR
    JAMA Netw Open; 2023 May; 6(5):e2316077. PubMed ID: 37256617
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma].
    Dourthe ME; Simonin M; Rigaud C; Haouy S; Montravers F; Ducou Le Pointe H; Garnier N; Minard-Colin V; Jo Molina T; Boudjemaa S; Leblanc T; Landman-Parker J
    Bull Cancer; 2023 Sep; 110(9):968-977. PubMed ID: 37062647
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic value of cross-lineage expression of the myeloid-associated antigens CD13 and CD33 in adult B-lymphoblastic leukemia: A large real-world study of 1005 patients.
    Liao H; Lai H; Chen J; Shuai X; Zhang X; Yang Y; Lyu M; Zheng Q
    Cancer Med; 2023 Apr; 12(8):9615-9626. PubMed ID: 36951610
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Spectrum of second primary malignancies and cause-specific mortality in pediatric and adult langerhans cell histiocytosis.
    Goyal G; Parikh R; Richman J; Abeykoon JP; Morlote D; Go RS; Bhatia S
    Leuk Res; 2023 Mar; 126():107032. PubMed ID: 36758375
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Analysis of 42 cases of childhood superior vena cava syndrome associated with mediastinal malignancy].
    Yang QS; Han YL; Cai JY; Gu S; Bai J; Ren H; Xu M; Zhang J; Zhang AA; Su M; Pan C; Wang Y; Tang JY; Gao YJ
    Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1026-1030. PubMed ID: 36207849
    [No Abstract]    [Full Text] [Related]  

  • 14. Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events.
    Jacobs SS; Withycombe JS; Castellino SM; Lin L; Mack JW; McFatrich M; Baker JN; Freyer DR; Maurer SH; Mowbray C; Hinds PS; Reeve BB
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29986. PubMed ID: 36151978
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent hodgkin lymphoma.
    Repetto O; Caggiari L; De Zorzi M; Elia C; Mussolin L; Buffardi S; Pillon M; Muggeo P; Casini T; Steffan A; Mauz-Körholz C; Mascarin M; De Re V
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077307
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Analysis of Agranulocytosis Time and Its Influencing Factors in Patients with Hematological Malignancies Treated with rhIL-11 combined rhG-CSF].
    Wei HM; Li ZJ; Wang LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):930-936. PubMed ID: 35680829
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Hematopoietic Stem-Cell Transplant Utilization in Relapsed/Refractory hodgkin lymphoma: A Population-Level Analysis of Statewide Claims Data.
    Waheed A; Rodday AM; Kumar AJ; Miller KB; Parsons SK
    JCO Clin Cancer Inform; 2022 May; 6():e2100135. PubMed ID: 35584337
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Retrospective single-center experience with OEPA/COPDAC and PET-CT based strategy for pediatric hodgkin lymphoma in a LMIC setting.
    Palayullakandi A; Trehan A; Jain R; Kumar R; Mittal BR; Kapoor R; Srinivasan R; Kakkar N; Bansal D
    Pediatr Hematol Oncol; 2022 Oct; 39(7):587-599. PubMed ID: 35271413
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Epstein-Barr Virus in Childhood and Adolescent Classic hodgkin lymphoma in a French Cohort of 301 Patients.
    Pereira V; Boudjemaa S; Besson C; Leblanc T; Rigaud C; Leruste A; Garnier N; Lambilliotte A; Simonin M; Curtillet C; Bonneau-Lagacherie J; Coulomb A; Landman-Parker J
    J Pediatr Hematol Oncol; 2022 Nov; 44(8):e1033-e1038. PubMed ID: 35091521
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Lymphoblastic lymphoma: a Concise Review.
    Intermesoli T; Weber A; Leoncin M; Frison L; Skert C; Bassan R
    Curr Oncol Rep; 2022 Jan; 24(1):1-12. PubMed ID: 35059993
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.